Navigation Links
Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
Date:5/18/2012

BOCA RATON, Fla., May 18, 2012 /PRNewswire/ -- Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center of Dallas, TX are proud to announce the establishment of the SRT University™ Comprehensive Education Series for practitioners, healthcare professionals, and patients. SRT University™ will offer multi-tiered education and training curriculums for the provider and patient populations.  The objectives are to increase the awareness and proficiency in utilizing superficial radiotherapy and its many benefits to treat non-melanoma skin cancers.

(Logo: http://photos.prnewswire.com/prnh/20110124/FL34943LOGO )

SRT University™ will provide physicians and healthcare professionals academic-grade expert training on the science, physics, practice workflow, and patient management pertaining to superficial radiotherapy in treating non-melanoma skin cancers.  Training will be delivered via online, live and on-demand broadcasts, and hands-on modules.

Dr. Dan McCoy, who will lead the clinician content development team, said, "We are extremely excited to be involved in this project with Sensus Healthcare to bring this treatment modality back to the forefront of skin cancer therapy in dermatology and to train practitioners and healthcare professionals to use this technology for optimal outcomes for our patients."

Joe Sardano, President and CEO of Sensus Healthcare, said, "We are honored and excited to partner with Dr. McCoy and his team in establishing a world-class expert education program that will benefit the patients, optimize clinical outcomes, and help the physicians and healthcare professionals to constantly hone their skills and essentially create an idea-sharing and knowledge proliferation professional community, while increasing patient awareness of superficial radiotherapy as a viable treatment option for their non-melanoma skin cancer."

About Sensus Healthcare:
Sensus Healthcare specializes in making proven non-melanoma skin cancer solutions more accessible to patients. Our dedicated superficial radiation therapy (SRT) systems are designed specifically to provide an alternative to surgical procedures for basal cell and squamous cell carcinomas. Our mobile, compact SRT-100™ systems are used widely by oncologists and dermatologists to bring non-melanoma skin cancer treatment to more patients in more settings. We also offer a professional skin care line, Sensus Skin Solutions™, through our physician SRT-100™ users for their patients.

About Texas Dermatology Associates at Baylor Medical Center:
Texas Dermatology Associates at Baylor Medical Center is a comprehensive clinic specializing in the treatment of a wide variety of skin diseases since 1974.  Dr. Alan Menter, Senior Partner, is internationally known for his work in the treatment of psoriasis, and Dr. Dan McCoy, Managing Partner, is Medical Director for the Baylor Sammons Cancer Center Skin Tumor and Melanoma Clinic.  Texas Dermatology is the primary clinical site for the Baylor University Medical Center Dermatology Residency Program.  The providers and staff at Texas Dermatology have contributed over 300 articles in prestigious medical journals, nationally and internationally, as well as lecturing extensively. The Menter Dermatology Research Institute is a leading innovator in dermatology research.

Contact:

Michelle Verina
Public Relations
561-922-5808 Ext 108
michelle@sensushealthcare.com


'/>"/>
SOURCE Sensus Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
2. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
3. Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer
4. TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare
5. Sensus Healthcare Awarded Sole Contract for Superficial Radiotherapy
6. Boston Scientific Second Quarter Results Exceed Consensus Sales and EPS; Full-Year Guidance Raised
7. 2011 Consensus Panel Issues New Guidelines for Intrathecal Pain Management
8. International Panel of Leading Bariatric Surgeons Reaches Consensus on Optimal Techniques for Laparoscopic Sleeve Gastrectomy
9. Ameritox Supports New Expert Consensus Recommendations For Patients on Long-Term Opioid Therapy
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 West Pharmaceutical Services, Inc. ... for injectable drug administration, today announced that it will ... on Thursday, October 26, 2017, and will follow with ... expectations at 9:00 a.m. Eastern Time. To participate on ... The conference ID is 94093362. ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... , Oct. 4, 2017  According to the Centers for Disease ... end of October . PhysicianOne Urgent Care is helping communities across ... Westchester, NY , by offering no-cost* flu shots through the end ... mandated by certain health insurance regulations. ... The best time to get a flu shot is by the end ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):